See More Hear More Watch More Hear More Get on iTunes
StrictlyVC StrictlyVC

AvidBiologics Raises Undisclosed Amount

AvidBiologics, a three-year-old, Toronto-based oncology drug development company, has raised an undisclosed amount of financing led by Lumira Capital, with participation from MaRS Investment Accelerator Fund, MaRS Innovation, and Rosseau Asset Management.


More from